Investigation of in vivo activated T cells in multiple sclerosis and inflammatory central nervous system diseases.

[1]  E. Reinherz,et al.  In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. , 1985, The New England journal of medicine.

[2]  E. Reinherz,et al.  Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody. , 1984, Journal of immunology.

[3]  T. Flotte,et al.  Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines. , 1984, Journal of immunology.

[4]  J. Strominger,et al.  Dual parameter flow cytometric analysis of DNA content, activation antigen expression, and T cell subset proliferation in the human mixed lymphocyte reaction. , 1984, Journal of immunology.

[5]  H. Weiner,et al.  Altered blood T-cell subsets in patients with multiple sclerosis , 1984, Journal of Neuroimmunology.

[6]  D. Cantrell,et al.  Transient expression of interleukin 2 receptors. Consequences for T cell growth , 1983, The Journal of experimental medicine.

[7]  J. Strominger,et al.  A 55,000 Mr surface antigen on activated human T lymphocytes defined by a monoclonal antibody. , 1983, Human immunology.

[8]  J. Golaz,et al.  Activated T lymphocytes in patients with multiple sclerosis , 1983, Neurology.

[9]  T. Miyawaki,et al.  Sequential expression of T cell activation (Tac) antigen and Ia determinants on circulating human T cells after immunization with tetanus toxoid. , 1983, Journal of immunology.

[10]  J. Strominger,et al.  Characterization of a novel differentiation antigen complex recognize by a monoclonal antibody (A-1A5): unique activation-specific molecular forms on stimulated T cells. , 1983, Journal of immunology.

[11]  J. Strominger,et al.  Simultaneous flow cytometric analysis of human T cell activation antigen expression and DNA content , 1983, The Journal of experimental medicine.

[12]  H. Weiner,et al.  Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. , 1983, The New England journal of medicine.

[13]  D. McFarlin,et al.  Multiple sclerosis (first of two parts). , 1982, The New England journal of medicine.

[14]  B. Haynes,et al.  Increased circulating Ia-antigen-bearing T cells in type I diabetes mellitus. , 1982, The New England journal of medicine.

[15]  E. Reinherz,et al.  Comparative expression of T9, T10, and Ia antigens on activated human T cell subsets. , 1981, Human immunology.

[16]  A. Munck,et al.  T cell growth factor receptors. Quantitation, specificity, and biological relevance , 1981, The Journal of experimental medicine.

[17]  J. Shelhamer,et al.  Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. , 1981, Journal of immunology.

[18]  K. Smith,et al.  T-cell growth factor and the culture of cloned functional T cells. , 1981, Advances in immunology.

[19]  L. Moretta,et al.  Surface antigens specifically expressed by activated T cells in humans , 1981, European journal of immunology.

[20]  E. Reinherz,et al.  Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies. , 1980, The New England journal of medicine.

[21]  R. Winchester,et al.  Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization , 1980, The Journal of experimental medicine.

[22]  T. Strom,et al.  Role of protein and RNA synthesis in the development of insulin binding sites on activated thymus-derived lymphocytes. , 1979, The Journal of biological chemistry.

[23]  Kendall A. Smith,et al.  Long term culture of tumour-specific cytotoxic T cells , 1977, Nature.

[24]  R. Gallo,et al.  Selective in vitro growth of T lymphocytes from normal human bone marrows. , 1976, Science.